Force-Mediated Membrane Fusion
力介导的膜融合
基本信息
- 批准号:9308993
- 负责人:
- 金额:$ 31.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-01 至 2020-06-30
- 项目状态:已结题
- 来源:
- 关键词:ActinsAdhesionsAdhesivesAffectAnimal ModelAtomic Force MicroscopyBinding ProteinsBiochemicalBiochemistryBiologicalBiological AssayBiologyBiophysicsCaenorhabditis elegansCell fusionCell membraneCellsCentrifugationChimeric ProteinsComplementComplexCongenital failure of fusionCoupledCrowdingCytoskeletonDataDefectDevelopmentEngineeringEpithelialEventFluorescence MicroscopyGeneticGenetic ScreeningIn VitroLinkLipid BilayersLipidsLocationMeasurementMeasuresMediatingMembraneMembrane FusionMethodsMonitorMuscleOpticsOrganismPlacentaPlayProcessPropertyProteinsResolutionRoleSiteTestingTimeTissuesVesicleViralVirusdensityin vivoinsightmechanical forcemembrane reconstitutionoptogeneticspolymerizationpublic health relevancereconstitutionsegregationtrafficking
项目摘要
DESCRIPTION (provided by applicant): Membrane fusion is ubiquitous in biology and required for processes as diverse as intracellular vesicle trafficking, viral entry, and fertilizaton. While the molecules responsible for intracellular vesicle fusion and virus-cell fusion have been studied extensively, much less is known about what controls fusion between two plasma membranes. Over the past decade, a new perspective has emerged that places forces generated by the actin cytoskeleton at the center of the complex sequence of events that results in cell-cell fusion. However, direct evidence of force-mediated membrane fusion is missing due to the difficulty of controlling mechanical force using genetics or biochemistry, leaving unanswered basic questions about the role of force in cell-cell fusion: How much force is needed? Is force necessary to clear proteins and form contact sites? Does force introduce membrane defects and/or promote fusogen activity? In this project, we propose to use in vitro membrane reconstitution combined with high-resolution optical and force microscopy to test the role of external forces on membrane fusion. We will focus on Epithelial fusion failure (Eff-1) protein from C. elegans, a recently- identified cell-cell fusogen whose fusogenic activity is associated with actin assembly in vivo. We hypothesize that fusogens and other proteins that destabilize the plasma membrane are needed to lower the energy barrier to fusion such that the actin cytoskeleton can complete the task, potentially providing a means to restrict cell-cell fusio to times and locations where force and fusogens act in concert. Using reconstituted membrane interfaces as well as live cells, we will quantify fusion efficiency and dynamics using combined fluorescence and force microscopy, and we will compare results with Eff-1 cell-cell fusogen to better-known intracellular and viral fusogens. The results of this study will provide a new biophysical perspective on cell-cell fusion, reveal the dynamic interplay between fusogens and force during fusion initiation, and complement cell-cell fusion studies in model organisms with mechanistic insight that is only possible from in vitro reconstitution.
描述(由申请人提供):膜融合在生物学中普遍存在,并且是细胞内囊泡运输、病毒进入和受精等多种过程所必需的。虽然负责细胞内囊泡融合和病毒-细胞融合的分子已被广泛研究,但对控制两个质膜之间融合的分子知之甚少。在过去的十年中,出现了一个新的观点,将肌动蛋白细胞骨架产生的力置于导致细胞-细胞融合的复杂事件序列的中心。然而,由于难以使用遗传学或生物化学控制机械力,力介导的膜融合的直接证据缺失,留下了关于力在细胞-细胞融合中的作用的未回答的基本问题:需要多大的力?清除蛋白质和形成接触部位是否需要外力?力是否引入膜缺陷和/或促进融合剂活性?在这个项目中,我们建议使用体外膜重建结合高分辨率光学和力显微镜来测试外力对膜融合的作用。我们将重点研究C. elegans,最近鉴定的细胞-细胞融合子,其融合活性与体内肌动蛋白组装相关。我们假设,融合蛋白和其他蛋白质,使质膜不稳定,需要降低融合的能量障碍,使肌动蛋白细胞骨架可以完成任务,潜在地提供了一种手段,以限制细胞-细胞融合的时间和地点的力量和融合蛋白一起行动。使用重组膜界面以及活细胞,我们将使用组合的荧光和力显微镜定量融合效率和动力学,我们将比较结果与Eff-1细胞-细胞融合剂更好地了解细胞内和病毒融合剂。这项研究的结果将提供一个新的生物物理学的角度对细胞-细胞融合,揭示融合启动过程中的融合因子和力之间的动态相互作用,并补充细胞-细胞融合研究的模式生物与机制的洞察力,这是唯一可能从体外重建。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIEL A FLETCHER其他文献
DANIEL A FLETCHER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIEL A FLETCHER', 18)}}的其他基金
Mechanical Regulation of Actin Binding Proteins
肌动蛋白结合蛋白的机械调节
- 批准号:
10582008 - 财政年份:2019
- 资助金额:
$ 31.4万 - 项目类别:
Mechanical regulation of actin binding proteins
肌动蛋白结合蛋白的机械调节
- 批准号:
10386857 - 财政年份:2019
- 资助金额:
$ 31.4万 - 项目类别:
A membrane encapsulation system for cellular reconstitution
用于细胞重建的膜封装系统
- 批准号:
9517912 - 财政年份:2015
- 资助金额:
$ 31.4万 - 项目类别:
A membrane encapsulation system for cellular reconstitution
用于细胞重建的膜封装系统
- 批准号:
9293334 - 财政年份:2015
- 资助金额:
$ 31.4万 - 项目类别:
A membrane encapsulation system for cellular reconstitution
用于细胞重建的膜封装系统
- 批准号:
9108992 - 财政年份:2015
- 资助金额:
$ 31.4万 - 项目类别:
A membrane encapsulation system for cellular reconstitution
用于细胞重建的膜封装系统
- 批准号:
8965379 - 财政年份:2015
- 资助金额:
$ 31.4万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 31.4万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 31.4万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 31.4万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 31.4万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 31.4万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 31.4万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 31.4万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 31.4万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 31.4万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 31.4万 - 项目类别: